Catalyst Wire Dossier Catalyst Wire Dossier

Carbidopa-Levodopa enteral suspension

carbidopa-levodopa enteral suspension · AbbVie
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Carbidopa-Levodopa enteral suspension, covering 2020-08-18 to 2020-08-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER) [Phase 3]

See pricing